BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$197.95

+4.50 (+2.33%)

As of May 11, 9:36 PM ET ·

Day Range $194.75 — $200.31

52W Range $115.25 — $202.41

Performance

1D —

1W —

1M —

3M +3.53%

6M +20.17%

1Y +59.12%

YTD +11.32%

Open$194.76

Previous Close$193.45

Day High$200.31

Day Low$194.75

52W High$202.41

52W Low$115.25

Volume—

Avg Volume1.05M

Market Cap28.76B

P/E Ratio22.25

EPS$8.81

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $179.51 Above

SMA 200 $150.33 Above

RSI (14) 64.3 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Buy

43 analysts

24 Buy 18 Hold 1 Sell

Price Target -53.8% upside

Current
$197.95

Target
$91.45

$57.23 $91.45 avg $114.90

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	10.00B	10.09B	3.09B
Net Income	1.31B	1.19B	745.08M
Profit Margin	13.1%	12.4%	24.1%
EBITDA	2.57B	2.47B	1.15B
Free Cash Flow	—	—	775.19M
Rev Growth	-0.9%	-0.9%	+20.7%
Debt/Equity	0.34	0.34	1.02

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$202.78	+0.61%	88.1	372.29B
AMGN	Amgen Inc	$329.59	-0.64%	22.7	176.88B
GILD	Gilead Sciences Inc	$133.52	+1.67%	19.3	163.92B
VRTX	Vertex Pharmaceuticals Inc	$435.17	+1.24%	27.7	109.50B
REGN	Regeneron Pharmaceuticals	$712.77	-0.30%	16.5	74.30B
ALNY	Alnylam Pharmaceuticals Inc	$284.84	-3.46%	130.4	40.90B